Browsing by Subject "Letter"

Article

About mentioning quality of preparation and quality control of radiopharmaceuticals used in nuclear medicine procedures [3]

Wozniak, Greta; Georgoulias, Panagiotis; Archimandritis, Spiros; Dimakopoulos, Nikolaos; Fezoulidis, Ioannis (2006)

Article

Commentary on pravastatin and cancer: Need for individual patient data meta-analyses

Bonovas, Stefanos; Nikolopoulos, Georgios K.; Sitaras, N. M. (2010)

Article

Comparative study of prognostic value for coronary disease risk between the U.K. prospective diabetes study and Framingham models: Response to Protopsaltis et al. [9] (multiple letters)

Stevens, R. J.; Holman, R.; Protopsaltis, I. D.; Nikolopoulos, Georgios K.; Melidonis, Andreas (2004)

Article

Docetaxel-induced enterocolitis: A serious and potentially fatal adverse event

Boussios, Stergios; Pentheroudakis, George; Kamina, S.; Katsanos, K.; Pavlidis, Nicholas (2011)

Article

The effect of tamoxifen therapy on serum apolipoprotein A-I level is modified by the apolipoprotein E phenotype

Liberopoulos, E. N.; Pavlidis, Nicholas; Elisaf, Moses S. (2001)

Article

The effects of a first-aid education program for middle school students in a Greek urban area

Rekleiti, Maria; Saridi, Maria; Toska, Aikaterini; Kyriazis, Ioannis; Kyloudis, Panagiotis; Souliotis, Kyriakos; Wozniak, Greta (2013)

Article

Efficacy and safety of more intensive lowering of LDL cholesterol [1]

Bonovas, Stefanos; Nikolopoulos, Georgios K.; Sitaras, N. M. (2011)

Article

Favorable outcome in non-Hodgkin lymphoma of the maxillary sinus treated with R-CHOP

Doumas, Stergios; Sakkas, L.; Panayiotidis, P.; Wozniak, Greta; Vlychou, M.; Vassilopoulos, G. (2014)

Article

Global curriculum edition 2016: European society for medical oncology/American society of clinical oncology recommendations for training in medical oncology

Dittrich, C.; Kosty, M. P.; Jezdic, S.; Pyle, D.; Berardi, Rossana; Bergh, Jonas; Nagi, S. E.-S.; Lotz, J. P.; Österlund, Pia; Pavlidis, Nicholas; Purkalne, Gunta (2017)

Article

A phase-II study with idarubicin, etoposide and prednisone (IVPP), in patients with refractory or early relapsed intermediate or high grade non- Hodgkin's lymphoma [6]

Xiros, N.; Economopoulos, T.; Fountzilas, George; Pavlidis, Nicholas; Samantas, E.; Raptis, S. (1999)

Article